NEWS & PERSPECTIVES

Psychedelics News

Curated updates on microdosing, research, policy, and community.

The latest

2026-04-22 • Seeing What Is There (Substack)

Trump's executive order about ibogaine should be swallowed with a lot of nitroglycerin

More heart failure than Rogan would like you to know about

2026-04-22 • Chemical Collective

The Difficulty of Sincerity After Psychedelics

Psychedelic experiences often heighten one’s sense of authenticity and sincerity, but this can make ordinary social interactions feel hollow or performative by comparison, creating difficulties in navigating everyday ...

2026-04-21 • Breaking Convention (Substack)

Less than a month away!

plus new lineup and talks announced!

2026-04-21 • Microdose (industry)

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

President Donald Trump’s April 2026 executive order on accelerating treatments for serious mental illness does something the psychedelic industry has been waiting for, and quietly fearing. It removes ambiguity. For ye...

2026-04-21 • ICEERS

Ten Years After UNGASS: The Gap Between Language and Practice

Ten years after UNGASS, the gap between human rights commitments and drug policy practice remains wide — particularly for communities whose relationships with traditional plant medicines sit outside the categories the...

2026-04-21 • Lucid News

Trump Signs Executive Order To Fast-Track Psychedelic Research

President Donald Trump signed an executive order aimed at accelerating clinical research and federal approval for psychedelic therapies especially ibogaine as mental health therapy for veterans. The post Trump Signs E...

Research Policy
2026-04-20 • Psychedelic Health

Trump Issues Executive Order to Accelerate Psychedelics for Mental Health

President Donald J. The post Trump Issues Executive Order to Accelerate Psychedelics for Mental Health appeared first on Psychedelic Health.

Policy
2026-04-20 • Psychedelics Today

Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways

The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core approval, scheduling and reimbursement hurdles in place. President Donald Trump on April 18 signed an e...

2026-04-20 • Filter Magazine (Psychedelics)

Trump Orders FDA to “Dramatically” Fast-Track Psychedelic Therapy Access

President Donald Trump has signed an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics, ... The post Trump Orders FDA to “Dramatically” Fast-Track Psyched...

2026-04-20 • Filter Magazine (Psychedelics)

Trump Orders FDA to “Dramatically” Fast-Track Psychedelic Therapy Access

President Donald Trump has signed an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics, ...

2026-04-20 • The Microdose (Berkeley)

Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion

Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.

2026-04-20 • DoubleBlind Magazine

5 Things We Learned at Psychedelic Culture 2026

Plus, ketamine addiction, DMT lasers, and plant medicine faeries [...] Read More... The post 5 Things We Learned at Psychedelic Culture 2026 appeared first on DoubleBlind Mag.

2026-04-19 • The Psychedelic Blog (Substack)

Global Altered States: The Storefront Psychedelic

This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.

2026-04-19 • Chemical Collective

Psychonautisme, Herbes et Suppléments

De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la neurochimie de notre corps, et cela devient particulièrement pertinent lorsqu’ils sont associés à des...

2026-04-18 • MAPS

MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy

April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements from Co-Executive Directors Betty Aldworth and Ismail L. Ali, J.D., on today’s Executive Order regardin...